Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens

Safeguarding patients from emerging infectious diseases demands strategies that prioritise patient well-being and protection. Immunobridging is an established trial methodology which has been increasingly employed to ensure patient protection and provide clinicians with swift access to vaccines. It...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Pedro Cruz, Jie Min Lam, Jehad Abdalla, Samira Bell, Jola Bytyci, Tal Brosh-Nissimov, John Gill, Ghady Haidar, Michael Hoerger, Yasmin Maor, Antonio Pagliuca, Francois Raffi, Ffion Samuels, Dorry Segev, Yuxin Ying, Lennard Y. W. Lee
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2024-12-01
סדרה:	Vaccines
נושאים:	immunobridging clinical trials immunocompromise vaccines monoclonal antibodies
גישה מקוונת:	https://www.mdpi.com/2076-393X/13/1/19
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!